Matthew Galsky

Title: Matthew Galsky: Innovator in Bicyclic Inhibitors

Introduction

Matthew Galsky is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific proteins.

Latest Patents

Galsky holds a patent for "Bicyclic inhibitors of CBX chromodomains." This patent discloses a genus of bicyclic inhibitors of CBX chromodomains. The compounds described in the patent are characterized by the presence of carbon or nitrogen, resulting in structures that are either indoles or benzimidazoles. A specific subgenus of 1,3-disubstituted-1,3-dihydro-2H-benzo[d]imidazol-2-imines is detailed, which has the potential to inhibit CBX proteins. He has 1 patent to his name.

Career Highlights

Matthew Galsky is affiliated with the Icahn School of Medicine at Mount Sinai, where he conducts research and develops innovative solutions in his field. His work focuses on the intersection of chemistry and biology, aiming to create effective therapeutic agents.

Collaborations

Galsky collaborates with Ming-Ming Zhou, a fellow researcher, to advance their shared goals in scientific discovery and innovation.

Conclusion

Matthew Galsky's contributions to the field of medicinal chemistry, particularly through his patent on bicyclic inhibitors, highlight his role as an innovator. His work at the Icahn School of Medicine at Mount Sinai continues to push the boundaries of scientific research and development.